methyl 2-cyclopropylthiazole-4-carboxylate | 1286744-59-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: methyl 2-cyclopropylthiazole-4-carboxylate
• 英文别名: methyl 2-cyclopropyl-1,3-thiazole-4-carboxylate
• CAS: 1286744-59-9
• 化学式: C₈H₉NO₂S
• 分子量: 183.231
• InChiKey: CPLITJZCMPATMH-UHFFFAOYSA-N

物化性质

• 沸点：
  280.5±13.0 °C(Predicted)
• 密度：
  1.327±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  67.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 2-cyclopropylthiazole-4-carboxylate 在 锂硼氢 作用下， 以 四氢呋喃 为溶剂， 以96 %的产率得到(2-cyclopropylthiazol-4-yl)methanol
  参考文献：
  名称：

  [EN] SUBSTITUTED 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE DERIVATIVES AND RELATED USES
  [FR] DÉRIVÉS DE 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE SUBSTITUÉS ET UTILISATIONS ASSOCIÉES

  摘要：

  The present disclosure relates to compounds of Formula (I): and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as inflammatory, autoinflammatory and autoimmune diseases and cancers.

  公开号：

  WO2023240134A1
• 作为产物：
  描述：

  2-溴噻唑-4-羧酸甲酯 、 环丙基硼酸 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 caesium carbonate 作用下， 以 水 、 甲苯 为溶剂， 以44 %的产率得到methyl 2-cyclopropylthiazole-4-carboxylate
  参考文献：
  名称：

  [EN] SUBSTITUTED 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE DERIVATIVES AND RELATED USES
  [FR] DÉRIVÉS DE 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE SUBSTITUÉS ET UTILISATIONS ASSOCIÉES

  摘要：

  The present disclosure relates to compounds of Formula (I): and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as inflammatory, autoinflammatory and autoimmune diseases and cancers.

  公开号：

  WO2023240134A1

文献信息

• [EN] PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES<br/>[FR] DÉRIVÉS DE PHÉNÉTHYLAMIDE ET LEURS ANALOGUES HÉTÉROCYCLIQUES
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2010044054A1

  公开（公告）日：2010-04-22

  The invention relates to novel phenethylamide derivatives and their heterocyclic analogues of formula (I), wherein A, B, R1, R2 and R3 are as described in the application, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.

  这项发明涉及新型苯乙酰胺衍生物及其异环类似物，其化学式为(I)，其中A、B、R1、R2和R3如申请中所述，并且涉及将这种化合物或这种化合物的药用可接受盐用作药物，特别是促进睡眠的药物受体拮抗剂。
• [EN] 2-AZA-BICYCLO[2.2.1]HEPTANE DERIVATIVES<br/>[FR] DÉRIVÉS DE 2-AZA-BICYCLO[2.2.1]HEPTANE
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2009104155A1

  公开（公告）日：2009-08-27

  The invention relates to novel 2-aza-bicyclo[2.2.1]heptane derivatives of formula (I), wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.

  这项发明涉及公式（I）中的新型2-aza-双环[2.2.1]庚烷衍生物，其中A、B、n和R1如描述中所述，并且涉及将这类化合物或这类化合物的药用盐用作药物，特别是用作促觉醒素受体拮抗剂。
• 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS
  申请人：Aissaoui Hamed

  公开号：US20110263662A1

  公开（公告）日：2011-10-27

  The invention relates to 1,2-diamido-ethylene derivatives of the formula (I) wherein R 1 , R 2 , R 3 , and A are as described in the description and their use as medicaments, especially as orexin receptor antagonists.

  这项发明涉及式(I)的1,2-二胺基乙烯衍生物，其中R1、R2、R3和A如描述中所述，并且它们作为药物的用途，特别是作为促觉醒素受体拮抗剂。
• 2-AZA-BICYCLO[3.3.0]OCTANE DERIVATIVES
  申请人：Aissaoui Hamed

  公开号：US20110009461A1

  公开（公告）日：2011-01-13

  The invention relates to 2-aza-bicyclo[3.3.0]octane derivatives of Formula (I) wherein A, B, and R 1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.

  这项发明涉及到式(I)中的2-aza-bicyclo[3.3.0]辛烷衍生物，其中A、B和R1如描述中所述，并且涉及到这些化合物的使用，或者这些化合物的药用盐的使用，作为药物，特别是作为促进睡眠的药物受体拮抗剂。
• [EN] PIPERIDINE AND PYRROLIDINE COMPOUNDS<br/>[FR] COMPOSÉS DE PIPÉRIDINE ET DE PYRROLIDINE
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2009133522A1

  公开（公告）日：2009-11-05

  The invention relates to piperidine and pyrrolidine compounds of formula (I) wherein A, B, n and X are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.

  该发明涉及式（I）中的哌啶和吡咯烷化合物，其中A、B、n和X如描述中所述；其药学上可接受的盐，以及将这些化合物用作药物，特别是促醒素受体拮抗剂。